Influenza vaccines - quality module

  • Email
  • Help
Current effective version

Revision 1 - Adopted guideline

Reference numberEMA/CHMP/BWP/310834/2012 Rev. 1
Published28/07/2017
Effective from01/02/2018
KeywordsQuality requirements, influenza vaccines, inactivated, LAIV, seasonal, zoonotic, pandemic preparedness, pandemic, annual strain update, pandemic strain update
DescriptionThis document provides guidance on marketing authorisation applications for influenza vaccines and for strain updates of authorised influenza vaccines. It applies to inactivated non-adjuvanted vaccines and inactivated vaccines with adjuvant to be used in the seasonal, pre-pandemic or pandemic setting, and live attenuated seasonal influenza vaccines. This quality module replaces the quality requirements of the guidelines listed under 'Superseded documents'.


Document history

Revision 1

Current version

Adopted guidelineIn operation: 01/02/2018-present
First version

Adopted guideline


 

Overview of comments


 

Draft guideline


 

Concept paper

In operation: 01/11/2014-01/02/2018


 

Published: 02/06/2014


 

Published: 08/03/2013


 

Published: 03/10/2011


Superseded documents


Related content


How helpful is this page?

Average rating:

 Based on 26 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
6 ratings
    

Tell us more